Dr. Leitenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-884-5000
Education & Training
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1990 - 1992
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
- University of IowaPh.D., 1990
- University of VermontB.A., 1983
Certifications & Licensure
- DC State Medical License 2001 - 2024
- CT State Medical License 1993 - 2001
- American Board of Pathology Clinical Pathology
Awards, Honors, & Recognition
- Commendation for teaching excellence and innovation Committee on Undergraduate Medical Education, 2013
- Recipient, Golden Apple Award for Teaching Excellence AMSA, 2011
- Nominated for Graduate Advisor of the Year Columbian College Arts and Sciences, 2007
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsInhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer.Stephanie Gomez, Olivia L Cox, Reddick R Walker 3rd, Uzma Rentia, Melissa Hadley
Journal for Immunotherapy of Cancer. 2022-11-01 - 10 citationsMajor Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican DescentKatherine Clarridge, David Leitenberg, Brett Loechelt, Capuchine Picard, Michael A. Keller
Journal of Clinical Immunology. 2016-01-01 - 21 citationsHLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering ApplicationsZaruhi Karabekian, Hao Ding, Gulnaz Stybayeva, Irina Ivanova, Narine Muselimyan
Tissue Engineering. Part A. 2015-09-08
Journal Articles
- Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican DescentClarridge, K., D. Leitenberg, B. Loechelt, C. Picard, M. Keller, J Clinical Immunol, 1/1/2016
- HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering ApplicationsKarabekian Z, Ding H, Stybayeva G, Ivanova I, Muselimyan N, Haque A, Toma I, Posnack NG, Revzin A, Leitenberg D, Laflamme MA, Sarvazyan N, Tissue Eng, 1/1/2015
- Ganglioside-treated dendritic cells inhibit T cell effector function by promoting regulatory T cell activityFalahati, R., E. Mari, A. Jales, E.J. Stemy, W. Shen, C. Southammokasone, D. Herzog, S. Ladisch, D. Leitenberg, Immunology, 1/1/2011
- Join now to see all
Books/Book Chapters
Lectures
- Tumor Immunology for PhD and MS level studentsMultiple Locations, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019 - 1/1/2019
- Clinical Flow CytometryGeorgetown University, 2018, 2019 - 1/1/2019
- Hypersensitivity ResponsesGeorgetown University, 2018, 2019 - 1/1/2019
- Join now to see all
Grant Support
- CD45 Regulation Of T Lymphocyte ActivationNational Institute Of Allergy And Infectious Diseases2001–2003
- CD45 Regulation Of T Lymphocyte ActivationNational Institute Of Allergy And Infectious Diseases1999–2000
- CD45 Isoform Regulation Of T Cell ActivationNational Institute Of Allergy And Infectious Diseases1995–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: